Once considered a “last resort” for those diagnosed with bone marrow cancer, bone marrow transplants (BMTs) have become a more successful treatment option in recent decades. As the number of BMTs performed around the world continues to rise, so do questions about its ethical complexities.
On Monday, September 25th, the Center for Healthcare Engineering & Patient Safety (CHEPS) partnered with Sung Won Choi, MD, MS and Jodyn Platt, MPH to discuss the intricacies of informed consent.
Bone marrow basics
Depending on the kind of cancer a patient is diagnosed with, there are different methods for BMT: while autologous transplants allow a person to “donate” their own pre-chemotherapy stem cells to themselves, allogeneic transplants require donation from another person. Continue Reading »